Multimodal Nano-DESI Mass Spectrometry Imaging Reveals Phospholipids Accumulation in and around Amyloid Plaques in Alzheimer’s Disease
ACS Chemical Neuroscience · 20.08.2025 · 16 (16) · 3127-3137
DOI: 10.1021/acschemneuro.5c00144 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 31.07.2025. Verfasst von Manxi Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States. Hauptthemen laut MEDLINE: Alzheimer Disease, Plaque, Amyloid, Phospholipids, Brain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: U.S. Department of Defense, National Institutes of Health, National Science Foundation.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD), characterized by β-amyloid plaques, is increasingly recognized by lipid dysregulation as a key factor in its pathology. Mass spectrometry imaging (MSI), a powerful tool for mapping the spatial distribution of biomolecules in tissue sections, is ideally suited for investigating region-specific molecular alterations in diseased animal tissues. Recent MSI advancements have revealed plaque-associated molecular features in the AD brain, highlighting the role of metabolic dysfunction in disease progression. In this study, we developed a novel multimodal MSI approach using nanospray desorption electrospray ionization (nano-DESI) for dual polarity mode lipid and peptide imaging in the brain tissues of 5-7-month-old transgenic familial AD mice (5xFAD), followed by fluorescence imaging of β-amyloid plaques on the same tissue section. Our results revealed the accumulation of several peptides and phospholipids, including phosphatidylethanolamines (PE), phosphatidylinositols (PI), phosphatidylglycerols (PG), and phosphatidylcholines (PC) in and/or surrounding β-amyloid plaques in the hippocampus, isocortex, and thalamus regions of the AD brain. Furthermore, we observed that several fatty acids (FAs) were enhanced in the plaque-enriched subiculum region of the hippocampus. Our results demonstrate the power of the multimodal nano-DESI MSI approach for comprehensive mapping of molecular pathology with high spatial resolution, providing unique insights into disease metabolism and potential biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States.
ORCID-Profile: Manxi Yang, Mushfeqa Iqfath, Emerson Hernly, Daisy Unsihuay, Zihan Qu, Gaurav Chopra, Julia Laskin
Förderung
- U.S. Department of Defense
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Yang, M., Tang, X., Iqfath, M., Hernly, E., Unsihuay, D., Manchanda, P., Sharma, K., Qu, Z., Hu, H., Beveridge, C., Chopra, G., & Laskin, J. (2025). Multimodal Nano-DESI Mass Spectrometry Imaging Reveals Phospholipids Accumulation in and around Amyloid Plaques in Alzheimer’s Disease. ACS Chemical Neuroscience, 16(16), 3127-3137. https://doi.org/10.1021/acschemneuro.5c00144
Vancouver
Yang M, Tang X, Iqfath M, Hernly E, Unsihuay D, Manchanda P, et al. Multimodal Nano-DESI Mass Spectrometry Imaging Reveals Phospholipids Accumulation in and around Amyloid Plaques in Alzheimer’s Disease. ACS Chemical Neuroscience. 2025;16(16):3127-3137. doi:10.1021/acschemneuro.5c00144
BibTeX
@article{Yang2025,
author = {Yang, Manxi and Tang, Xindi and Iqfath, Mushfeqa and Hernly, Emerson and Unsihuay, Daisy and Manchanda, Palak and Sharma, Kaushik and Qu, Zihan and Hu, Hang and Beveridge, Connor and Chopra, Gaurav and Laskin, Julia},
title = {Multimodal Nano-DESI Mass Spectrometry Imaging Reveals Phospholipids Accumulation in and around Amyloid Plaques in Alzheimer’s Disease},
journal = {ACS Chemical Neuroscience},
year = {2025},
volume = {16},
number = {16},
pages = {3127--3137},
doi = {10.1021/acschemneuro.5c00144}
}
EUVIMED